Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
French biotech company is raising capital for R&D and debt refinancing
-
The Finnish biopharmaceutical company tapped shareholders for capital on Thursday night
-
The €813m deal is multiple times covered
-
Pharma company wins blowout order book as investors pile in for yield
-
IPO was covered throughout the initial range on day one
-
The medical equipment company is funding its acquisition of Icelandic peer Kerecis with equity